Skip to content

Nektar Therapeutics

US · NKTR #3017 by market cap Listed 1970
30.20 -2.34 -7.19%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Nektar Therapeutics

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Founded
1990
CEO
Mr. Howard W. Robin
Employees
63
Headquarters
San Francisco, California, United States of America
Fiscal year end
12-31
Website
nektar.com

Company profile

Exchange
US
Symbol
NKTR
Market-cap rank
#3017
Listing date
1970-01-01
Market cap
1.03B
Float cap
864.00M
Shares out
34.21M
Float shares
28.61M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 20:02:35 · For reference only, not investment advice and not tailored to your situation.

Nektar Therapeutics discussion 0 comments

Add a comment